title: Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer.
authors.affiliation: Medical Oncology Department, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada Faculty of Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Jacques
authors.initials: J
authors.lastname: Raphael
authors.affiliation: Faculty of Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: I Y
authors.initials: IY
authors.lastname: Gong
authors.affiliation: Pathology Department, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Nofech-Mozes
authors.affiliation: Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
authors.forename: Jms
authors.initials: J
authors.lastname: Bartlett
authors.affiliation: Pathology Department, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Nafisi
authors.affiliation: Medical Oncology Department, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada Faculty of Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Verma
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000378:metabolism*; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001940:Breast / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D012189:Retrospective Studies; D017154:Stromal Cells / Q000378:metabolism / Q000473:pathology; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C508053:ERBB2 protein, human
keywords: BREAST CANCER; CERB 2; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE MARKERS; MACROPHAGES